The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

Delgocitinib is a JAK inhibitor that blocks the activation of the JAK-STAT pathway which has been shown to play a key role in the pathophysiology of chronic inflammatory skin diseases.

The FDA has approved a new treatment, sold under the name Anzupgo and containing a drug called delgocitinib, as the first skin cream for adults with long-term or chronic hand eczema (CHE), which ...

The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

When it comes to your baby’s delicate skin, especially on their face, finding the right moisturiser isn’t just a nice-to-have, it’s a must. Baby skin is thinner and more sensitive than adult skin, ...

EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare gene ...

We chatted with dermatologists to find out what LED light therapy devices can and cannot do for your skin when it comes to ...

One in 10 people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. These quick facts can help you manage it.

With so many cellulite treatments out there, it can be hard to know what, if anything, works. Research shows some treatments can make cellulite less noticeable.